{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 87: The Trifecta Heart Study: Assessing Donor Specific Antibodies in AMR","description":"JHLT: The Podcast returns for July with a paper entitled \u201cComparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study,\u201d available online now and in the July print issue of JHLT. Today\u2019s guests are first author Katelynn S. Madill-Thomsen, PhD and senior author Philip F. Halloran, MD, PhD, both from the Alberta Transplant Applied Genomics Center in Canada. In the episode, the authors and editors discuss:  Striking similarities\u2014and key differences\u2014in the DSA-negative and DSA-positive groups Changes to clinical practice based on the findings, including innovations from the kidney transplant community Future studies, including tools and therapies that could be explored for improved clinical outcomes  For the latest studies from JHLT, visit www.jhltonline.org\/current, or, if you\u2019re an ISHLT member, access your Journal membership at www.ishlt.org\/jhlt. Don't already get the&amp;nbsp;Journal&amp;nbsp;and want to read along? Join the International Society of Heart and Lung Transplantation at&amp;nbsp;www.ishlt.org&amp;nbsp;for a free subscription, or subscribe today at&amp;nbsp;www.jhltonline.org. ","author_name":"JHLT: The Podcast","author_url":"http:\/\/thejhlt.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41911295\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/203616590"}